8-K filing — Instil Bio, Inc. (TIL)
Filed: 2026-08-13 AccNo: 0001789769-26-000055 Size: 253 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Instil Bio Q2 Adj. EPS $(0.45) Misses $(0.43) Estimate
Instil Bio (NASDAQ:TIL) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.43) by 4.65 percent. This is a 84.37 percent increase over losses of $(2.88) per share from the
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 13, 2026, 9:03 PM
- Checked
- Aug 13, 2026, 9:03 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading